|Listed in category:
The seller is away until 28 Jun, 2024. If you buy this item, expect a delay in delivery.
Have one to sell?

Networks of Innovation: Vaccine Development at Merck, Sharp and Dohme, and Mul..

US $39.98
ApproximatelyAU $60.24
or Best Offer
Condition:
Brand new
Postage:
US $4.99 (approx. AU $7.52) Economy postage. See detailsfor delivery
Located in: Fairhope, Alabama, United States
Delivery:
Estimated between Mon, 1 Jul and Fri, 5 Jul to 43230
Delivery time is estimated using our proprietary method which is based on the buyer's proximity to the item location, the postage service selected, the seller's postage history, and other factors. Delivery times may vary, especially during peak periods.
Returns:
30-day returns. Buyer pays for return postage. See details- for more information about returns
Payments:
     

Shop with confidence

eBay Money Back Guarantee
Get the item you ordered or your money back. Learn moreeBay Money Back Guarantee - opens new window or tab
Seller assumes all responsibility for this listing.
eBay item number:305561153681
Last updated on 13 May, 2024 09:45:24 AESTView all revisionsView all revisions

Item specifics

Condition
Brand new: A new, unread, unused book in perfect condition with no missing or damaged pages. See the ...
Country/Region of Manufacture
United States
ISBN
9780521563086
Subject Area
Medical, History
Publication Name
Networks of Innovation : Vaccine Development at Merck, Sharp and Dohme, and Mulford, 1895-1995
Publisher
Cambridge University Press
Item Length
9.3 in
Subject
United States / 20th Century, Preventive Medicine
Publication Year
1996
Type
Textbook
Format
Hardcover
Language
English
Item Height
0.8 in
Author
Louis P. Galambos
Item Weight
18.6 Oz
Item Width
6.2 in
Number of Pages
320 Pages

About this product

Product Information

Networks of Innovation offers an historical perspective on the manner in which private-sector organizations have acquired, sustained, and periodically lost the ability to develop, manufacture, and market new serum antitoxins and vaccines. The primary focus is on the H. K. Mulford Company, on Sharp and Dohme, which acquired Mulford in 1929, and upon Merck & Co Inc., which merged with Sharp and Dohme in 1953. By surveying a century of innovation in biologicals, the authors are able to analyze the conditions that either promoted or prevented creative changes in this important industry. They show how the activities of these three commercial enterprises were related to a series of complex, evolving networks of scientific, governmental, and medical institutions in the United States and abroad. This is the first such history to draw exclusively on sources internal to Merck, one of the world's leading innovators in modern vaccines and pharmaceuticals.

Product Identifiers

Publisher
Cambridge University Press
ISBN-10
0521563089
ISBN-13
9780521563086
eBay Product ID (ePID)
469095

Product Key Features

Number of Pages
320 Pages
Language
English
Publication Name
Networks of Innovation : Vaccine Development at Merck, Sharp and Dohme, and Mulford, 1895-1995
Publication Year
1996
Subject
United States / 20th Century, Preventive Medicine
Type
Textbook
Subject Area
Medical, History
Author
Louis P. Galambos
Format
Hardcover

Dimensions

Item Height
0.8 in
Item Weight
18.6 Oz
Item Length
9.3 in
Item Width
6.2 in

Additional Product Features

Dewey Edition
21
Reviews
'The work is admirably referenced and will be of value to all who take an interest in the field of biologicals. It will repay careful reading by those involved in the management of innovation in the pharmaceutical industry.' John Hunt, The Pharmaceutical Journal, "Galambos and Sewell's well-documented book is a valuable and unusual contribution to the history of specialized pharmaceutical endeavor in America, with emphasis on the networking required on the long road leading to each new vaccine." Glenn Sonnedecker, American Historical Review, 'The work is admirably referenced and will be of value to all who take an interest in the field of biologicals. It will repay careful reading by those involved in the management of innovation in the pharmaceutical industry.'John Hunt, The Pharmaceutical Journal, ‘The work is admirably referenced and will be of value to all who take an interest in the field of biologicals. It will repay careful reading by those involved in the management of innovation in the pharmaceutical industry.’John Hunt, The Pharmaceutical Journal, "...best described by its subtitile because of the narrow focus on the chronological history of Merck's vaccine unit." Book Reviews, "Rigorously researched and crisply written, Networks of Innovation....makes a strong case for science-based firms' building and sustaining organizational capabilities to achieve technological innovation as well as to accomodate shifting competitive and regulatory environments." David B. Sicilia, The Journal of American History, "...this is a most impressive work....superb at showing the requisites for successful vaccine innovation. It provides outside observers rare insight into decision making processes at a leading pharmaceutical firm." Marvin Fischbaum, H-Net Reviews, "Networks of Innovation deserves a careful and thoughtful reading by historians of technology because it shows how it is possible to analyze effectively the role of individuals in the process of technological change without losing the insights and rigor that come from sociological and economic theory." W. Bernard Carlson, Technology and Culture
As Told to
Sewell, Jane Eliot
Target Audience
Trade
Illustrated
Yes
Dewey Decimal
615.1/9/00973
Lc Classification Number
Rm281.G35 1997
Table of Content
Preface; 1. 1894: 'The foremost medical question of the day'; 2. The Mulford story; 3. A Sharp & Dohme interlude; 4. The virology network and a new programme at Merck, Sharp & Dohme; 5. Hilleman's innovations: first phase, measles-mumps-rubella; 6. Dangerous interlude, Marek's Disease adjuvant 65, the Swine Flu drama; 7. Transforming bacteriology: a second phase, meningitis, pneumonia, haemophilus, influenzae; 8. New networks, new leadership: the Hepatitis B vaccines; 9. Vaccine innovation in the nineties: new strategies, new structures, and public confrontations; A word about sources.

Item description from the seller

Morebks2

Morebks2

100% positive Feedback
7.4K items sold
Joined May 2006
Usually responds within 24 hours

Detailed seller ratings

Average for the last 12 months

Accurate description
5.0
Reasonable postage costs
5.0
Postage speed
5.0
Communication
5.0

Seller Feedback (2,533)

k***k (426)- Feedback left by buyer.
Past month
Verified purchase
Extremely fast response from seller when a question was asked. Book was packaged extremely well, seller obviously cares about books. Extremely happy with seller and this transaction.
u***c (140)- Feedback left by buyer.
Past 6 months
Verified purchase
Books in good condition. As described. Packed well for travel. Thanks for the prompt shipment. Buy from this seller with confidence!
1***s (7)- Feedback left by buyer.
Past 6 months
Verified purchase
Book was as described. It arrived promptly and was packaged professionally. Would buy from this seller again

Product ratings and reviews

No ratings or reviews yet.
Be the first to write the review.